EN DE
STOCK COMPARISON

Alibaba Health Information Technology vs ShuYu Civilian Pharmacy Corp.: Fair Value & Quality

Both stocks run through our valuation models. Here is how Alibaba Health Information Technology (0241) and ShuYu Civilian Pharmacy Corp. (301017) compare, as of Sep 24, 2026.

As of Sep 24, 2026, Fair Value Calculator sees Alibaba Health Information Technology as the less overvalued of the two: Alibaba Health Information Technology trades at HK$2.84 versus a fair value of HK$2.03 (-28%), while ShuYu Civilian Pharmacy Corp. trades at ¥12.95 versus ¥5.91 (-54%).
Alibaba Health Information Technology
0241.HK · HKD · Health Care
-28%
upside to fair value
overvalued
PriceHK$2.84
Fair ValueHK$2.03
Quality64/100
ShuYu Civilian Pharmacy Corp.
301017.SHE · CNY · Consumer Staples
-54%
upside to fair value
overvalued
Price¥12.95
Fair Value¥5.91
Quality60/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

Alibaba Health Information TechnologyShuYu Civilian Pharmacy Corp.
Valuation
22.0×P/E (TTM)51.8×
1.45×P/S (TTM)0.50×
2.79×P/B2.46× · book value is mostly goodwill
30.4×EV/EBITDA22.1×
0.70×PEGn/a
−28.4%Fair value upside−54.4%
n/aDividend yield0.3%
n/aDividend per share¥0.05
Profitability
2%Operating margin2%
n/aEBIT margin trend (5Y)0.31×
11%Return on equity5%
4%Return on assets1%
Growth
8%Revenue growth (YoY)9%
8.6%Avg. growth/yr (3Y)9.7%
17.2%Avg. growth/yr (5Y)17.4%
+36.9%Value creation/yr+4.1%
Balance & size
1,357.4×Interest coverage (EBIT/interest)1.8×
n/aDebt / equity0.56×
$6BMarket cap$784M
healthyGrowth qualityhealthy
Valuation multiples (P/E, P/S, P/B, EV/EBITDA) are shown but not scored here: the two companies sit in different sectors, and multiples only compare fairly between similar business models. PEG stays scored, as it relates the P/E to growth.

Alibaba Health Information Technology leads: 4 to 2 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Alibaba Health Information Technologyof which business quality 64 · market factors 13 ShuYu Civilian Pharmacy Corp.of which business quality 58 · market factors 37
ProfitabilityMargins and returns on capital today
60
41
Quality GrowthAre margins and returns improving?
56
69
CashflowEarnings quality: real cash, not paper profit
43
62
Fin. StrengthBalance sheet, leverage, solvency risk
97
32
InvestmentDisciplined investing over empire-building
85
90
Low VolatilityCalm price path (market factor)
26
50
MomentumPrice trend over the last 3–12 months (market factor)
12
33
52W MomentumDistance to the 52-week high (market factor)
0
27
Net IssuanceShare count: buybacks or dilution?
47
82

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyAlibaba Health Information TechnologyPrice HK$2.84ShuYu Civilian Pharmacy Corp.Price ¥12.95
DCF Models+4%close to the priceHK$2.94+57%above the price¥20.34
Earnings-Based+48%above the priceHK$4.20-70%below the price¥3.91
Multiples-28%below the priceHK$2.03-49%below the price¥6.60
Asset-Based-74%below the priceHK$0.74-73%below the price¥3.52
Growth DCF-7%close to the priceHK$2.65+82%above the price¥23.58
Economic Profit-58%below the priceHK$1.18-70%below the price¥3.94
Growth Earnings+97%above the priceHK$5.58-56%below the price¥5.68
Minimum-74%below the priceHK$0.74-73%below the price¥3.52
Maximum+97%above the priceHK$5.58+82%above the price¥23.58
Median-7%close to the priceHK$2.65-56%below the price¥5.68
Geometric mean-19%below the priceHK$2.28-45%below the price¥7.17

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Alibaba Health Information Technology: 15 of 24 models see the stock below the current price.

ShuYu Civilian Pharmacy Corp.: 13 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

Alibaba Health Information Technology
Price HK$2.84
Fair Value HK$2.03
Bear HK$1.36Bull HK$3.07
ShuYu Civilian Pharmacy Corp.
Price ¥12.95
Fair Value ¥5.91
Bear ¥4.44Bull ¥7.39

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Alibaba Health Information Technology · Health Care

Quality score64 · Top 25%
Fair value upside-28% · below median

ShuYu Civilian Pharmacy Corp. · Consumer Staples

Quality score60 · above median
Fair value upside-54% · bottom 25%

Bottom line

As of Sep 24, 2026, Fair Value Calculator sees Alibaba Health Information Technology as the less overvalued of the two: Alibaba Health Information Technology trades at HK$2.84 versus a fair value of HK$2.03 (-28%), while ShuYu Civilian Pharmacy Corp. trades at ¥12.95 versus ¥5.91 (-54%).

Alibaba Health Information Technology has the higher quality score (64/100).

Open Alibaba Health Information Technology live analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.